Journals / Gülhane Tıp Dergisi / 2008 / Cilt: 50 - Sayı: 3

Recurrent urinary tract infections

Rekürren üriner sistem enfeksiyonları

Pages
226–231
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Use of vaccines and hyaluronic acid are currently under investigation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Urinary tract infections are one of the most common bacterial infections in especially women, and approximately one forth of these show a recurrence.
📊
Key Findings & Data:Most of these infections do not have any complications.
💡
Conclusion & Impact:Use of vaccines and hyaluronic acid are currently under investigation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tanı · Tekrarlama · Risk faktörleri

Abstract

Urinary tract infections are one of the most common bacterial infections in especially women, and approximately one forth of these show a recurrence. Most of these infections do not have any complications. Several factors are suggested responsible for the recurrence of urinary tract infections. Of these, there are sexual intercourse, use of contraceptives, antimicrobials and oestrogen, genetic factors, and the short distance between the anus and urethra. Escherichia coli is the most common microorganism causing urinary tract infections. A variety of choices are present in the treatment. Long-term treatment, prophylaxis after intercourse, treatment initiated by the patient, and prophylactic estrogen and cranberry juice use are examples of treatment modalities. Use of vaccines and hyaluronic acid are currently under investigation.

Özet

Üriner sistem enfeksiyonları özellikle kadınlarda en sık görülen bakteriyel enfeksiyonlardandır ve yaklaşık dörtte birinde tekrarlayıcı karakterdedir. Bu enfeksiyonların büyük çoğunluğu komplikasyon oluşturmaz. Bir çok faktör, üriner sistem enfeksiyonlarının tekrarından sorumlu tutulmuştur. Bunlar arasında; cinsel aktiviteler, kontraseptif kullanımı, antimikrobiyal kullanımı, östrojen, genetik faktörler ve anüs ile üretra arasındaki mesafenin kısalığını sayabiliriz. Bu enfeksiyonlardan en yaygın olarak Escherichia coli bakterileri sorumlu tutulur. Tedavide değişik seçenekler uygulanmaktadır. Uzun süreli tedavi veya cinsel temas sonrası profilaksi ve hastanın kendiliğinden başladığı tedavi, profilaktik olarak östrojen ve yabanmersini suyu kullanılması gibi seçenekler bu kapsamda sayılabilir. Aşı seçenekleri ve hyaluronik asid kullanımı halen araştırılmaktadır.

🔖

Cite This Article

COŞKUN, Ö. (2008). Recurrent urinary tract infections. Gülhane Tıp Dergisi, Cilt: 50 - Sayı: 3, 226–231. https://ajindex.com/articles/226182

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Franco AVM. Recurrent urinary tract infections. Best Pract Res Clin Obstetr Gynecol 2005; 19: 861-873
  2. Sobel JD, Kaye D. Urinary tract infection. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone, 1995: 662-690
  3. Ünal S, Akalın H. Üriner sistem infeksiyonları. In: Kanra G, Akalın E. İnfeksiyon Hastalıkları. 2nci baskı. Ankara: Güneş Kitabevi, 1993: 167-189
  4. Kunin CM. Urinary tract infections in females. Clin Infect Dis 1994; 18: 1-12
  5. Stamm WE, Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infection. Clin Infect Dis 1999; 28: 723-725
  6. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997; 11: 551-581
  7. Foxman B, Marsh J, Gillespie B, Rubin N, Koopman JS, Spear S. Condom use and first-time urinary tract infection. Epidemiology 1997; 8: 637-641
  8. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent UTI in young women. J Infect Dis 2000; 182: 1177-1182
  9. Stamm WE. Aproach to the patient with urinary tract infection. In: Gorbach SL, Barlett JG, Blacklow NR (eds). Infectious Diseases. Philedelphia: WB Saunders Company, 1992: 788-798
  10. Meares EM. Current patterns in nosocomial urinary tract infections. Urology 1991; 37: 9-12
  11. Özsüt H, Çalangu S. İdrar yolu infeksiyonları. In: Willke Topçu A, Söyletir G, Doğanay M (eds). İnfeksiyon Hastalıkları. İstanbul: Nobel Tıp Kitabevi, 1996:921-926
  12. Hooton TM, Stamm WE. The vajinal flora and UTIs. In: Mobley HLT, Warren JW (eds). UTIs: Molecular Pathogenesis and Clinical Management. Washington, DC: ASM Press, 1996: 67-94
  13. Hooton TM, Winter C, Tiu F, Stamm WE. Association of acute cystitis with the state of the menstrual cycle in young women. Clin Infect Dis 1996; 23: 635-636
  14. Raz R, Stamm WE. A controlled trial of intravaginal pestriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329:753-756
  15. Robinson D, Cardozo L. Oestrogen and the lower urinary tract. BJOG 2004; 111: 10-14
  16. Gupta K, Stamm WE. Pathogenesis and management of reccurent urinary tract infections in women. World J Urol 1999; 17: 415-420
  17. Ishıtoya S, Yamamoto S, Mitsumori K, Ogawa O, Terai A. Non-secretor status is associated with female acute uncomplicated pyelonephritis. BJU Int 2002; 89:851-854
  18. Lomberg H, Cedergren B, Leffler H, Ni